The ECS system has also been shown to downregulate a number of angiogenesis-inducing factors such as angiopoietin-2, placental growth factor and vascular endothelial growth factor (VEGF) that play a key role in tumor growth and new vessel formation (Hinz and Ramer, 2022). Here, VEGFA is linked to neoplasm.